BridgeBio Pharma stockBBIO
BridgeBio Pharma trades at $74.27, 20.5% below its 52-week high (Jul 9, 2026). The price is above its 50- and 200-day averages, i.e. in an uptrend. −2.9% year to date, +18.5% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Feb 25, 2027.
Ratings, candles, signals and the screener for BBIO — after you log in
Open the terminalFrequently asked questions about BridgeBio Pharma
What is the BridgeBio Pharma stock price?
At the close on Nov 5, 2026: $74.27 (−4.65% on the day). 52-week high: $93.42 on Jul 9, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does BridgeBio Pharma report earnings?
The next quarterly report is on Feb 25, 2027. Last quarter, earnings per share changed +56% year over year, revenue +193%.
Does BridgeBio Pharma pay dividends?
No, BridgeBio Pharma does not pay dividends.
Where does BridgeBio Pharma trade and how to buy it?
Ticker BBIO, exchange Nasdaq, listed since 2019. You can buy it through a broker with access to US exchanges.
Should I buy BridgeBio Pharma now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for BBIO are in the terminal after you log in.